To include your compound in the COVID-19 Resource Center, submit it here.
RGEN to pursue therapeutic HIV vaccine
was to announce today that its agreement with
Merck & Co. Inc.
has been modified to allow
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury